Trial intelligence / Profile preview

Abilify and Depakote maintenance in bipolar disorder

NCT00545675Phase 4Completed

Sponsor
Otsuka Holdings
Start
Dec 2007
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in bipolar disorder (BD), sponsored by Otsuka Holdings. Started Dec 2007; status: completed.

02

Drugs

aripiprazole
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00545675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00545675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call